Difference between revisions of "Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5 (Q9823)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1589975872009) |
(Created claim: Page(s) (P105): 2530-2538, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (8 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / First Author string | |||||||||||||||
| + | Oberneder R | ||||||||||||||
| Property / First Author string: Oberneder R / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1016/j.ejca.2006.05.029 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 16930989 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2006
| ||||||||||||||
| Property / Publication Date: 2006 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Eur. J. Cancer | ||||||||||||||
| Property / Published In Name String: Eur. J. Cancer / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 42 | ||||||||||||||
| Property / Volume: 42 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English) | ||||||||||||||
| Property / title: A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 2530-2538 | ||||||||||||||
| Property / Page(s): 2530-2538 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| links / sliswiki / name | links / sliswiki / name | ||||||||||||||
| + | |||||||||||||||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Oberneder R
0 references
2006
0 references
Eur. J. Cancer
0 references
42
0 references
A phase I study with adecatumumab a human antibody directed against epithelial cell adhesion molecule in hormone refractory prostate cancer patients (English)
0 references
2530-2538
0 references
